Colfax Corporation (CFX)
(Delayed Data from NYSE)
$30.27 USD
+0.52 (1.75%)
Updated May 3, 2019 04:02 PM ET
After-Market: $30.27 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$30.27 USD
+0.52 (1.75%)
Updated May 3, 2019 04:02 PM ET
After-Market: $30.27 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Why Is Colfax (CFX) Down 4.2% Since Last Earnings Report?
by Zacks Equity Research
Colfax (CFX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Colfax (CFX) Q4 Earnings & Revenues Surpass Estimates, Up Y/Y
by Zacks Equity Research
Colfax's (CFX) fourth-quarter 2021 net sales increase 23.6% year over year on impressive performance across its segments.
Colfax (CFX) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Colfax (CFX) delivered earnings and revenue surprises of 3.51% and 2.15%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Colfax (CFX) Exhibits Strong Prospects, Headwinds Persist
by Zacks Equity Research
Colfax (CFX) is poised to benefit from its exposure in diverse end markets, acquired assets and solid demand for its products. However, rising costs and high debt levels remain concerns.
Altra Industrial (AIMC) Q4 Earnings Miss, '22 View Solid
by Zacks Equity Research
Altra Industrial's (AIMC) Q4 earnings reflect the impacts of end-market strength, supply-chain restrictions, labor issues, and a hike in costs and expenses. It predicts y/y growth in 2022 earnings.
MRC Global (MRC) Q4 Earnings Top Estimates, Sales View Solid
by Zacks Equity Research
MRC Global (MRC) Q4 earnings reflect the impacts of strengthening U.S. and Canada segments, pandemic woes on international operations, and improved margins. It predicts y/y growth in 2022 revenues.
Colfax (CFX) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Colfax (CFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Allegion (ALLE) Q4 Earnings Top Estimates, '22 View Solid
by Zacks Equity Research
Allegion's (ALLE) Q4 earnings reflect the impacts of supply-chain restrictions, shortages of components, high costs and expenses, and effective pricing. It predicts y/y growth in 2022 earnings.
EnerSys (ENS) Tops on Q3 Earnings, Expects Q/Q Growth for Q4
by Zacks Equity Research
EnerSys' (ENS) Q3 earnings reflect the impacts of strengthening end markets, effective pricing actions, forex woes and high costs and expenses. It projects quarter-over-quarter growth for Q4 earnings.
RBC Bearings (ROLL) Q3 Earnings Top Estimates, Q4 View Solid
by Zacks Equity Research
RBC Bearings' (ROLL) Q3 earnings reflect the impacts of industrial markets' strength, weakness in defense, the DODGE buyout synergies and high costs. It expects year-over-year growth in Q4 revenues.
iRobot (IRBT) Records Q4 Loss, Supply Woes Persist in Q1
by Zacks Equity Research
iRobot's (IRBT) Q4 earnings reflect the impacts of shipping delays, shortages of semiconductor chips and lower margins. Sequentially, it predicts wider loss and lower revenues for Q1.
Crown Holdings (CCK) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Crown (CCK) delivered earnings and revenue surprises of 7.79% and 9.22%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Kennametal (KMT) Q2 Earnings Lag Estimates, High Taxes Hurt
by Zacks Equity Research
Kennametal's (KMT) Q2 earnings reflect the impacts of strengthening end markets (excluding transportation), improved margins and high taxes. It expects sequential growth in sales for Q3.
Xylem (XYL) Tops Q4 Earnings Estimates, Hurt by Supply Woes
by Zacks Equity Research
Xylem's (XYL) Q4 earnings reflect the impacts of the weak Measurement & Control Solutions segment and supply-chain woes. It expects 1H22 performance to suffer from supply woes.
Illinois Tool (ITW) Tops on Q4 Earnings, Gives Impressive View
by Zacks Equity Research
Illinois Tool's (ITW) Q4 earnings reflect the impacts of organic sales growth, MTS buyout synergies, supply-chain woes, and cost inflation. Earnings and sales are likely to increase y/y in 2022.
Parker-Hannifin (PH) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Parker-Hannifin (PH) delivered earnings and revenue surprises of 15.84% and 3.12%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
IDEX (IEX) Lags on Q4 Earnings, Projects Y/Y Growth for 2022
by Zacks Equity Research
IDEX's (IEX) Q4 earnings reflect the impacts of strength in segmental businesses and synergies from acquired assets. It predicts year-over-year growth in earnings per share for 2022.
Stanley Black (SWK) Q4 Earnings Beat, Down Y/Y on Supply Woes
by Zacks Equity Research
Stanley Black's (SWK) Q4 earnings reflect the impacts of buyout synergies, favorable pricing, lower volumes and cost inflation. It predicts year-over-year growth in earnings per share for 2022.
Graco (GGG) Beats on Q4 Earnings & Sales, Faces Cost Woes
by Zacks Equity Research
Graco's (GGG) Q4 earnings reflect gains from solid segmental and regional results. Cost inflation and supply-chain woes impact margins. It projects organic sales growth for 2022.
Colfax's (CFX) Product Strength Aids Amid Cost & Supply Woes
by Zacks Equity Research
Colfax (CFX) benefits from solid product offerings and focus on innovation, healthy demand and acquisition synergies. Cost inflation and supply-chain woes are concerning.
Cintas (CTAS) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Cintas (CTAS) Q2 earnings likely to reflect a healthy first-aid cabinet service, demand for personal protective products, innovation capabilities, and high freight, taxes, wages and energy costs.
Colfax (CFX) Meets Earnings Estimates in Q3, Lowers View
by Zacks Equity Research
Colfax's (CFX) Q3 earnings reflect the impacts of improved sales, margin expansion, supply-chain woes and logistics issues. For 2021, it lowers earnings projections on high taxes and pandemic woes.
Ingersoll (IR) on Buyout Spree, To Acquire Tuthill Pump Group
by Zacks Equity Research
Ingersoll's (IR) buyout of Tuthill Pump Group will help strengthen existing pumping solution offerings in the Precision and Science Technologies segment.
Colfax (CFX) Q3 Earnings Match Estimates
by Zacks Equity Research
Colfax (CFX) delivered earnings and revenue surprises of 0.00% and 1.57%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Colfax (CFX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Colfax (CFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.